Literature DB >> 7834202

Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.

F L Ricciardolo1, J A Nadel, P D Graf, C Bertrand, S Yoshihara, P Geppetti.   

Abstract

1. In the present study, we have investigated the role of kinins in allergen-induced bronchoconstriction. 2. Anaesthetized guinea-pigs were sensitized to ovalbumin, ventilated artificially, pretreated with atropine (1.4 mumol kg-1, i.v.) and total pulmonary resistance (RL) measured. In preliminary studies in the presence of the neutral endopeptidase inhibitor, phosphoramidon (4.5 mumol kg-1, i.v.), the bradykinin B2 receptor antagonist Hoe 140 (0.1 mumol kg-1, i.v.) completely abolished the increase in RL following aerosolized bradykinin (1 mM, 40 breaths), but had no effect on the increase in RL following aerosolized neurokinin A (NKA, 10 microM, 40 breaths). On the other hand, a combination of the NK1 (CP-96,345, 2 mumol kg-1, i.v.) and NK2 (SR 48968, 0.3 mumol kg-1, i.v.) tachykinin receptor antagonists abolished completely the increase in RL produced by NKA and partially inhibited the increase in RL produced by bradykinin. These results confirm previous studies that suggest that bradykinin induces the release of tachykinins from sensory nerves in guinea-pig airways. 3. Aerosolized ovalbumin (0.5%, 5 breaths) increased RL in sensitized guinea-pigs pretreated with atropine (1.4 mmol kg-1, i.v.), an effect that began within 2 min and reached a maximum within 5 min; RL remained above baseline at 20 min. Pretreatment with the bradykinin B2 receptor antagonist, Hoe 140, decreased the bronchoconstrictor effect of ovalbumin markedly at 10 to 20 min. In the presence of phosphoramidon (4.5 mumol kg-1, i.v.) the inhibition induced by Hoe 140 was apparent earlier and remained over the 20 min period of study. 4. Pretreatment with a combination of NK1 (CP-96,345) and NK2 (SR 48968) tachykinin receptor antagonists also markedly inhibited ovalbumin-induced bronchoconstriction; addition of the bradykinin B2 receptor antagonist to the NK1 and NK2 tachykinin receptor antagonists had no additional inhibitory effect on antigen-induced bronchoconstriction.5. These findings confirm that activation of sensory nerves to release tachykinins in guinea-pig airways contribute to antigen-induced bronchoconstriction, and provide evidence that tachykinin release is due to kinins generated during the allergic response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834202      PMCID: PMC1510098          DOI: 10.1111/j.1476-5381.1994.tb17018.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart.

Authors:  P Geppetti; C A Maggi; F Perretti; S Frilli; S Manzini
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation.

Authors:  A Saria; C R Martling; Z Yan; E Theodorsson-Norheim; R Gamse; J M Lundberg
Journal:  Am Rev Respir Dis       Date:  1988-06

3.  Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo.

Authors:  D J Dusser; E Umeno; P D Graf; T Djokic; D B Borson; J A Nadel
Journal:  J Appl Physiol (1985)       Date:  1988-12

4.  Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea-pig asthmatic response to ovalbumin inhalation.

Authors:  C J Dunn; G A Elliott; J A Oostveen; I M Richards
Journal:  Am Rev Respir Dis       Date:  1988-03

5.  Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants.

Authors:  J M Lundberg; A Saria
Journal:  Nature       Date:  1983 Mar 17-23       Impact factor: 49.962

6.  A potent nonpeptide antagonist of the substance P (NK1) receptor.

Authors:  R M Snider; J W Constantine; J A Lowe; K P Longo; W S Lebel; H A Woody; S E Drozda; M C Desai; F J Vinick; R W Spencer
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

7.  Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs.

Authors:  M P Kaufman; H M Coleridge; J C Coleridge; D G Baker
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-03

8.  Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.

Authors:  M Ichinose; M G Belvisi; P J Barnes
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

9.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.

Authors:  F J Hock; K Wirth; U Albus; W Linz; H J Gerhards; G Wiemer; S Henke; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man.

Authors:  J M Lundberg; T Hökfelt; C R Martling; A Saria; C Cuello
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

View more
  6 in total

1.  Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.

Authors:  A Rawlingson; N P Gerard; S D Brain
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.

Authors:  F L Ricciardolo; M Trevisani; P Geppetti; J A Nadel; S Amadesi; C Bertrand
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 3.  Coughing precipitated by Bordetella pertussis infection.

Authors:  Matthew Hewitt; Brendan J Canning
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

4.  Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.

Authors:  T Sakamoto; P J Barnes; K F Chung
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

Review 5.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

6.  Pharmacology of Bradykinin-Evoked Coughing in Guinea Pigs.

Authors:  Matthew M Hewitt; Gregory Adams; Stuart B Mazzone; Nanako Mori; Li Yu; Brendan J Canning
Journal:  J Pharmacol Exp Ther       Date:  2016-03-21       Impact factor: 4.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.